Journal Report

Drug Development Research

Download PDF
Journal Information
Journal Title
Drug Development Research
Publisher
John Wiley & Sons Inc.
ISSN
0272-4391
E-ISSN
1098-2299
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
A Two‐Pronged Attack Against Multidrug Resistance in Hepatocellular Carcinoma Offered by Natural Triterpenoid Saponin Raddeanin A
Jing‐Yi Chen, Yu‐Cheng Ho, Yu‐Ning Teng
2026-11-18 Vol. 87 Issue 8
Targeting RAS Signaling Pathways: Molecular Regulation, FDA‐Approved Inhibitors, Clinical Advances, and Patent Innovations
Ajad Chauhan, Vineet Prajapati, Ankit Kumar Singh et al.
2026-11-18 Vol. 87 Issue 8
Structural Optimization of Pyrimidine‐Based EGFR Inhibitors Against Resistance Mutations in NSCLC
V. M. Megha, Amrita Thakur, Sreeharsha Nagaraja et al.
2026-11-17 Vol. 87 Issue 8
mRNA‑Encoded Antibodies as a Powerful Arsenal Against Superbugs‐Induced Sepsis
Shuchen Pei, Zhaofei Guo, Linlin Cheng et al.
2026-11-15 Vol. 87 Issue 8
Small Molecule‐Mediated Nrf2 Activation as a Neuroprotective Approach in Multiple Sclerosis
Arnav Borole, Kevin Boguszewski, Philip Furmanski et al.
2026-11-15 Vol. 87 Issue 8
Issue Information
2026-11-15 Vol. 87 Issue 8
Oxopyrrolidine–Acylhydrazone Scaffolds as Dual Inducers of Autophagy and Ferroptosis in the Breast Cancer via JNK/Beclin‐1/GPX4 Regulation
Monisha Yadav H. S., Min Hee Yang, Omantheswara Nagaraja et al.
2026-11 Vol. 87 Issue 7
Preclinical Evaluation of cRGD‐Functionalized Lipid–Polymer Hybrid Nanocarriers for Anti‐VEGF Gene Therapy in Triple‐Negative Breast Cancer
Busra Cesur Ergun, Devrim Demir‐Dora
2026-11 Vol. 87 Issue 7
Discovery of New Quinoxaline, Tetracyclic‐Quinoxaline, and Imidazo[2,1‐ <i>a</i> ]isoindole Derivatives as Potent Antibacterial Candidates Targeting DNA Gyrase and Topoisomerase IV With Molecular Modeling Simulations
Ahmed Ragab, Mohga Basseem, Dina S. Aboul‐Magd et al.
2026-11 Vol. 87 Issue 7
SU5, a Stable Auraptene Analog, Ameliorates Metabolic Dysfunction‐Associated Steatohepatitis Through Modulation of the FXR Signaling Pathway
Fen Wen, Jing Chen, Lei Zhu et al.
2026-10-29 Vol. 87 Issue 7
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 20, 2026 16:56